UBS Group’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
+8,500
New +$1.12M ﹤0.01% 5524
2025
Q3
Sell
-21,100
Closed -$2.01M 10584
2025
Q2
$2.01M Buy
21,100
+12,100
+134% +$982K ﹤0.01% 4810
2025
Q1
$714K Buy
+9,000
New +$974K ﹤0.01% 5571
2023
Q1
Sell
-2,262
Closed -$445K 9939
2022
Q4
$445K Sell
2,262
-36,082
-94% -$7.48M ﹤0.01% 4810
2022
Q3
$7.12M Sell
38,344
-16,448
-30% -$3.25M ﹤0.01% 2060
2022
Q2
$9.83M Sell
54,792
-9,355
-15% -$2.39M ﹤0.01% 1836
2022
Q1
$21.8M Sell
64,147
-26,317
-29% -$8.89M 0.01% 1349
2021
Q4
$33.5M Buy
90,464
+22,102
+32% +$8.37M 0.01% 1218
2021
Q3
$27M Buy
68,362
+25,906
+61% +$11.9M 0.01% 1270
2021
Q2
$19.5M Buy
42,456
+11,719
+38% +$4.72M 0.01% 1506
2021
Q1
$11.5M Sell
30,737
-31,971
-51% -$13M ﹤0.01% 1837
2020
Q4
$22.6M Buy
62,708
+6,065
+11% +$1.93M 0.01% 1266
2020
Q3
$17M Buy
56,643
+10,280
+22% +$3.54M 0.01% 1281
2020
Q2
$16.7M Sell
46,363
-15,317
-25% -$4.93M 0.01% 1183
2020
Q1
$16.4M Buy
61,680
+50,372
+445% +$14.1M 0.01% 1090
2019
Q4
$3.65M Hold
11,308
﹤0.01% 2910
2019
Q3
$3.35M Sell
11,308
-8,121
-42% -$2.39M ﹤0.01% 2775
2019
Q2
$6.96M Sell
19,429
-7,299
-27% -$2.3M ﹤0.01% 2057
2019
Q1
$8.08M Buy
26,728
+21,588
+420% +$6.3M ﹤0.01% 1833
2018
Q4
$1.5M Hold
5,140
﹤0.01% 3311
2018
Q3
$1.83M Hold
5,140
﹤0.01% 3291
2018
Q2
$1.4M Hold
5,140
﹤0.01% 3489
2018
Q1
$1.18M Hold
5,140
﹤0.01% 3581
2017
Q4
$1.09M Hold
5,140
﹤0.01% 3713
2017
Q3
$996K Hold
5,140
﹤0.01% 3709
2017
Q2
$868K Buy
+5,140
New +$889K ﹤0.01% 3736
2016
Q1
Sell
-1,336
Closed -$250K 7870
2015
Q4
$250K Hold
1,336
﹤0.01% 4498
2015
Q3
$229K Hold
1,336
﹤0.01% 4525
2015
Q2
$284K Sell
1,336
-11,411
-90% -$2.23M ﹤0.01% 4557
2015
Q1
$2.3M Buy
12,747
+9,149
+254% +$1.72M ﹤0.01% 2805
2014
Q4
$646K Buy
+3,598
New +$634K ﹤0.01% 3955

Other funds holding ILMN

UBS Group's ILMN Position: Q1 2026 in Review

UBS Group reduced its Illumina (ILMN) stake by 24% in Q1 2026, selling an estimated $47.3M and leaving 1,162,435 shares worth $143M. The position accounts for 0.02% of the portfolio, ranked #791.

UBS Group first reported a position in ILMN in Q4 2014 and has held it in 46 quarters since. The position peaked at $200M in Q4 2025. 845 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • UBS Group held 1,162,435 shares of Illumina worth $143M as of Q1 2026.
  • UBS Group sold 359,888 Illumina shares in Q1 2026, an estimated $47.3M.
  • Illumina made up 0.02% of UBS Group's portfolio in Q1 2026, its #791 holding.
  • UBS Group first reported a position in Illumina in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Illumina position peaked at $200M in Q4 2025.
  • 845 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.